English  |  正體中文  |  简体中文  |  總筆數 :2853469  
造訪人次 :  45149893    線上人數 :  931
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"huang t c"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 41-65 / 347 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-02-14T07:10:34Z A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein–Barr Virus SHAN-CHI YU; Ko K.-Y.; Teng S.-C.; Huang T.-C.; Lo H.-T.; Cheng C.-L.; Yao M.; Hong R.-L.; Chen C.-N.; Chen T.-C.; Yang T.-L.
臺大學術典藏 2022-02-14T07:10:33Z Investigating early progression of Hodgkin lymphoma in a two-center analysis Yu T.-C.; SHAN-CHI YU; Wang R.-C.; Lai S.-F.; Teng C.-L.J.; Lin J.-W.; Lin W.-L.; Huang T.-C.
臺大學術典藏 2022-02-07T07:49:00Z Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏 2022-02-07T03:29:06Z Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Lin C.-C.; Chen Y.-J.; Cheng A.-L.; CHIH-HUNG HSU
臺大學術典藏 2022-02-07T03:29:04Z Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites Guo J.-C.; Lin C.-Y.; Lin C.-C.; Huang T.-C.; Lien M.-Y.; Lu L.-C.; Kuo H.-Y.; CHIH-HUNG HSU
臺大學術典藏 2022-01-12T07:07:42Z WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system HSIN-AN HOU; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.
臺大學術典藏 2022-01-12T07:07:16Z Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; HSIN-AN HOU; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; Tang J.-L.
臺大學術典藏 2022-01-12T07:07:11Z ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; HSIN-AN HOU; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F.
臺大學術典藏 2022-01-12T07:07:09Z Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience Wang Y.-W.; Tsai X.C.-H.; HSIN-AN HOU; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M.
臺大學術典藏 2022 Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy Huang T.-C.; Liang C.-W.; Li Y.-I.; Guo J.-C.; Lin C.-C.; Chen Y.-J.; Cheng A.-L.; CHIH-HUNG HSU
臺大學術典藏 2022 B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Hsu C.-L.; Huang Y.-L.; Lin C.-C.; Huang T.-C.; Wu I.-C.; Lin C.-Y.; Lien M.-Y.; Kuo H.-Y.; Cheng A.-L.; CHIH-HUNG HSU; Guo J.-C.
臺大學術典藏 2022 Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma CHIH-HUNG HSU; Cheng A.-L.; Lien M.-Y.; Kuo H.-Y.; Lin C.-Y.; Huang T.-C.; Hsu C.-L.; Lin C.-C.; Guo J.-C.
國立成功大學 2022 The Milestone of Improving Quality of Care in Chronic Kidney Disease Patients - Sodium Glucose Cotransporter 2 Inhibitors [慢性腎臟病照護的新里程碑-SGLT2抑制劑] Huang, T.-C.;Chang, Y.-T.
國立成功大學 2022 Lack of direct association between viral hepatitis and sleep disturbances Lin, S.-J.;Tang, S.-C.J.;Lee, Y.-C.;Liu, T.-Y.;Huang, T.-C.;Yu, R.-L.;Tan, C.-H.
臺大學術典藏 2021-10-27T03:22:20Z Clonal sequence tracking reveals TET2-mutated extranodal NK/T-cell lymphoma disseminated independent of Epstein Barr virus CHANG-TSU YUAN; Huang T.-C.; Chuang C.-C.; Chuang Y.-K.; Tsai J.-H.; Liau J.-Y.; Lin C.-W.; Tang J.-L.
臺大學術典藏 2021-09-15T01:20:59Z Quantitative proteomics reveals middle infrared radiation-interfered networks in breast cancer cells Chang H.-Y.; Li M.-H.; Huang T.-C.; CHIA-LANG HSU; Tsai S.-R.; Lee S.-C.; Huang H.-C.; Juan H.-F.
臺大學術典藏 2021-09-02T02:29:18Z A high ZIF-8 loading PVA mixed matrix membrane on alumina hollow fiber with enhanced ethanol dehydration Lin G.-S;Chen Y.-R;Chang T.-H;Huang T.-C;Zhuang G.-L;Huang W.-Z;Liu Y.-C;Matsuyama H;Wu K.C.-W;Tung K.-L.; Lin G.-S; Chen Y.-R; Chang T.-H; Huang T.-C; Zhuang G.-L; Huang W.-Z; Liu Y.-C; Matsuyama H; Wu K.C.-W; Tung K.-L.; KEVIN CHIA-WEN WU
臺大學術典藏 2021-09-01T02:02:18Z Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer Yeh K.H.; Lu Y.S.; Hsu C.H.; Lin J.F.; Chao H.J.; Huang T.C.; Chung C.Y.; Chang C.S.; Yang C.H.; ANN-LII CHENG
臺大學術典藏 2021-09-01T01:54:29Z Weekly 24-hour infusional 5-fluorouracil as initial treatment for advanced gastric cancer with acute disseminated intravascular coagulation Huang T.-C.; Yeh K.-H.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-09-01T01:54:26Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu C.; Kuo S.-H.; Hu F.-C.; ANN-LII CHENG; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏 2021-09-01T01:53:45Z Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy Chen W.-W.; Lin C.-C.; Huang T.-C.; ANN-LII CHENG; Yeh K.-H.; Hsu C.-H.
臺大學術典藏 2021-08-31T06:29:48Z Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-08-31T06:29:24Z Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; ANN-LII CHENG; Tzen K.-Y.; Hsu C.-H.
臺大學術典藏 2021-08-31T03:33:42Z Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer Weng R.R.; Lu H.-H.; Lin C.-T.; Fan C.-C.; Lin R.-S.; Huang T.-C.; SHU-YUNG LIN; Huang Y.-J.; Juan Y.-H.; Wu Y.-C.; Hung Z.-C.; Liu C.; Lin X.-H.; Hsieh W.-C.; Chiu T.-Y.; Liao J.-C.; Chiu Y.-L.; Chen S.-Y.; Yu C.-J.; Tsai H.-C.
臺大學術典藏 2021-08-18T07:39:09Z Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma JHE-CYUAN GUO; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; Cheng A.-L.; Hsu C.-H.

顯示項目 41-65 / 347 (共14頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目